One driving factor for developing preeclampsia—a pregnancy disorder, often associated with poor spiral artery (SpA)-remodeling and fetal growth restriction—is the anti-angiogenic sFLT1 (soluble ...
aThe Robinson Research Institute, School of Paediatrics and Reproductive Health, University of Adelaide, SA, Australia bWomen's Health Research Unit, Barts and the London School of Medicine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results